OREM, UT--(Marketwire - June 17, 2009) - Reflect Scientific, Inc. (OTCBB: RSCF), a supplier of scientific equipment to life science and manufacturing industries, announced that the Company had entered into a Financial Advisory and Investment Banking Agreement to help facilitate the Company’s internal growth by identifying appropriate sources of capital and advising on various development plans and strategies for their implementation. The Investment Banking firm, previously engaged by Reflect, was successful in identifying growth capital for the Company’s early development, and thus was reengaged.
Recent government environmental mandates and a growing demand for cost effective Cleantech alternatives to current mechanical driven ultra-low-temperature freezing systems has prompted management to identify new product opportunities. The Investment Banking agreement is intended to assist Reflect Scientific in identifying ways to capture new product sales opportunities and provide greater resources for the marketing of Test & Measurement and Cryogenic Cooling technologies.
“During the past year, our management team has been actively working to manage the Company’s growth and provide products that parallel ‘Clean Technologies’ and cost savings. Many of Reflect’s products increase power efficiency, reduce exhaust particulates, and decrease compliance costs. We have over 15 patents issued, filed or in process, covering our core technologies. With the expansion of our business, the need for an experienced Investment Banking relationship is extremely important,” remarked Mr. Kim Boyce, CEO of Reflect Scientific.
About Reflect Scientific, Inc.
Reflect Scientific, Inc. and its subsidiaries provide products for life science, biotechnology and pharmaceutical industries, as well as tools and analytical services for industrial manufacturing. For more information, visit www.reflectscientific.com.
Forward-looking statements in this release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company’s products, increased levels of competition for the Company, new products and technological changes, the Company’s dependence on third-party suppliers, and other risks detailed from time to time in the Company’s periodic reports filed with the Securities and Exchange Commission.
For information related to the Reflect Scientific, contact Investor
Relations:
Michael Dancy
801-746-3570
Email Contact
www.reflectscientific.com
